Consell de Barris de Les Planes

Wegovy, known as semaglutide in its generic form, has recently gained approval in the UK as a groundbreaking weight loss treatment. Developed by Novo Nordisk, this medication is administered via injection and works by mimicking a hormone called GLP-1, which regulates appetite and food intake. Clinical trials have shown https://wegovyuk.org/shop/ to be highly effective in promoting weight loss among individuals struggling with obesity, with many patients experiencing significant reductions in body weight and improvements in related health markers such as blood pressure and cholesterol levels. The approval of Wegovy in the UK offers new hope for individuals seeking effective and sustainable solutions for weight management, particularly those for whom traditional diet and exercise interventions have been insufficient.